Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial (Q33882778)

29 July 2017

Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial (English)

1 reference

29 July 2017

0 references

1 reference

6

Demetrius Albanes

1 reference

29 July 2017

Alan R Kristal

10

0 references

Marian L Neuhouser

series ordinal

7

object named as

Marian L Neuhouser

1 reference

29 July 2017

1

Elizabeth A Platz

1 reference

29 July 2017

3

Phyllis J Goodman

1 reference

29 July 2017

2

Cathee Till

1 reference

29 July 2017

4

Howard L Parnes

1 reference

29 July 2017

William D Figg

5

1 reference

29 July 2017

Eric A Klein

series ordinal

8

1 reference

29 July 2017

Ian M Thompson

series ordinal

9

1 reference

29 July 2017

language of work or name

1 reference

3 November 2009

1 reference

Cancer Epidemiology, Biomarkers & Prevention

29 July 2017

1 reference

29 July 2017

18

1 reference

29 July 2017

11

1 reference

29 July 2017

2807-2813

1 reference

Association between plasma cholesterol and prostate cancer in the PSA era.

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877916

Do the cholesterol-lowering properties of statins affect cancer risk?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877916

Statin use and prostate cancer risk in a large population-based setting

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877916

Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877916

Statin use and the risk of 10 cancers.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877916

Statin drugs and risk of advanced prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877916

Statins and prostate cancer risk: a case-control study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877916

Cholesterol and prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877916

The influence of finasteride on the development of prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877916

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877916

Association of low plasma cholesterol with mortality for cancer at various sites in men: 17-y follow-up of the prospective Basel study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877916

Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877916

Cancer incidence in the National Health and Nutrition Survey I. Follow-up data: diabetes, cholesterol, pulse, and physical activity

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877916

Serum cholesterol and risk of cancer in a cohort of 39,000 men and women

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877916

Heart disease risk factors, diabetes, and prostatic cancer in an adult community.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877916

Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877916

Statin use and risk of prostate cancer in the California Men's Health Study cohort

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877916

Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877916

Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877916

Trends in serum lipids and lipoproteins of adults, 1960-2002.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877916

Hypertriglyceridemia as a possible risk factor for prostate cancer.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877916

Implementation of the Prostate Cancer Prevention Trial (PCPT).

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877916

Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877916

Epidemiologic musing on statin drugs in the prevention of advanced prostate cancer

29 October 2018

1 reference

12 December 2020

Serum cholesterol and cancer in the Hypertension Detection and Follow-up Program

1 reference

12 December 2020

Effect of Finasteride on the Sensitivity of PSA for Detecting Prostate Cancer

1 reference

12 December 2020

Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer

1 reference

12 December 2020

Cholesterol-lowering drugs and advanced prostate cancer incidence in a large U.S. cohort

1 reference

12 December 2020

Inverse association between serum total cholesterol and cancer mortality in Dutch civil servants

1 reference

12 December 2020

Site-specific analysis of total serum cholesterol and incident cancer in the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study

1 reference

12 December 2020

10.1158/1055-9965.EPI-09-0472

Identifiers

DOI

1 reference

29 July 2017

1 reference

29 July 2017

1 reference